Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
$3.01M Sell
49,711
-27
-0.1% -$1.53K 0.29% 70
2024
Q1
$2.83M Buy
49,738
+14,163
+40% +$850K 0.27% 79
2023
Q4
$2.23M Sell
35,575
-4,539
-11% -$257K 0.23% 89
2023
Q3
$2.32M Buy
40,114
+19,021
+90% +$1.2M 0.26% 80
2023
Q2
$1.31M Buy
21,093
+4,955
+31% +$331K 0.14% 123
2023
Q1
$1.17M Sell
16,138
-301
-2% -$23.5K 0.13% 129
2022
Q4
$1.32M Buy
16,439
+257
+2% +$19.7K 0.15% 131
2022
Q3
$1.08M Sell
16,182
-847
-5% -$62.6K 0.14% 123
2022
Q2
$1.29M Sell
17,029
-174
-1% -$13.2K 0.16% 115
2022
Q1
$1.37M Buy
17,203
+3,130
+22% +$228K 0.15% 115
2021
Q4
$1.03M Sell
14,073
-9,719
-41% -$655K 0.11% 131
2021
Q3
$1.64M Buy
23,792
+2,100
+10% +$160K 0.21% 103
2021
Q2
$1.82M Buy
21,692
+1,846
+9% +$154K 0.23% 97
2021
Q1
$1.61M Buy
19,846
+6,315
+47% +$539K 0.23% 95
2020
Q4
$1.18M Buy
13,531
+4,073
+43% +$352K 0.18% 101
2020
Q3
$848K Buy
9,458
+4,308
+84% +$416K 0.14% 117
2020
Q2
$535K Buy
5,150
+597
+13% +$57.6K 0.1% 132
2020
Q1
$333K Buy
+4,553
New +$344K 0.07% 166
2018
Q4
Sell
-15
Closed -$1K 502
2018
Q3
$1K Buy
+15
New +$1.03K ﹤0.01% 922

Other funds holding INCY

Girard Partners's INCY Position: Q2 2024 in Review

Girard Partners reduced its Incyte (INCY) stake by 0.05% in Q2 2024, selling an estimated $1.53K and leaving 49,711 shares worth $3.01M. The position accounts for 0.29% of the portfolio, ranked #70.

Girard Partners first reported a position in INCY in Q3 2018 and has held it in 19 quarters since. 582 funds tracked by Wall St. Rank hold INCY as of Q2 2024.

  • Girard Partners held 49,711 shares of Incyte worth $3.01M as of Q2 2024.
  • Girard Partners sold 27 Incyte shares in Q2 2024, an estimated $1.53K.
  • Incyte made up 0.29% of Girard Partners's portfolio in Q2 2024, its #70 holding.
  • Girard Partners first reported a position in Incyte in Q3 2018 and has held it in 19 quarters since.
  • 582 funds tracked by Wall St. Rank held Incyte as of Q2 2024.

Based on Girard Partners's 13F filing for Q2 2024, filed 12 Aug 2024.